Treating Early-Stage CKD With New Medication Therapies: Results of a CKD Patient Survey Informing the 2020 NKF-FDA Scientific Workshop on Clinical Trial Considerations for Developing Treatments for Early Stages of Common, Chronic Kidney Diseases

RATIONALE & OBJECTIVE: With a growing number of medications and therapies available to treat chronic kidney disease (CKD), risk-versus-benefit discussions are increasingly critical. Balancing risks and benefits requires assessing patients’ understanding of these, as well as incorporating patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Damron, Kelli Collins, Friedman, Robert, Inker, Lesley A., Thompson, Aliza, Grams, Morgan E., Guðmundsdóttir, Hrefna, Willis, Kerry, Manley, Tom, Heerspink, Hiddo L., Weiner, Daniel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967726/
https://www.ncbi.nlm.nih.gov/pubmed/35372821
http://dx.doi.org/10.1016/j.xkme.2022.100442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967726/
https://www.ncbi.nlm.nih.gov/pubmed/35372821
http://dx.doi.org/10.1016/j.xkme.2022.100442

Ejemplares similares